Vaxcyte, Inc. — Director's Dealing 2026

Jan 16, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2026-01-14

Reporting Person: GUGGENHIME ANDREW (PRESIDENT AND CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-14	Common Stock	G	61850	—	Disposed	62459	Direct
2026-01-14	Common Stock	G	61850	—	Acquired	61850	Indirect

Footnotes

F1: The reported transaction involves the Reporting Person's transfer of shares to ALG 2025 GRAT HOLDINGS LLC, of which Reporting Person is the sole member and manager.

F2: Shares are held by ALG 2025 GRAT HOLDINGS LLC, of which 100% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person is the sole annuitant and trustee.